Kidney Stones : Some people taking topiramate may develop kidney stones
Gaining momentum Lilly has gained sales momentum in head-to-head competition with Novo Nordisk to bring to market GLP-1 drugs for obesity and diabetesled by tirzepatide, marketed for adult type 2 diabetes as Mounjaro and for obesity as Zepbound
Common outcomes include: Gradual and sustainable weight loss Noticeable appetite reduction Improved portion control Fewer cravings Better metabolic stability Oral GLP-1 therapy is not one-size-fits-all
The Common Threads of Fibromyalgia and Chronic Fatigue Syndrome from Everyday Health, by Dennis Thompson Jr, medically reviewed by Lindsey Marcellin, MD, MPH, reviewed November 23, 2011, viewed on February 27, 2023
Increased energy and metabolic efficiency from B12 shots may help those looking to lose weight feel more motivated and able to exercise
Nausea, vomiting, diarrhea, and reduced appetite may make it easier to consume fewer fluids throughout the day